In silico clinical studies for optimal COVID-19 vaccination schedules in patients with cancer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 38508146.
- Also identified by DOI 10.1016/j.xcrm.2024.101436 and PMC identifier 10982978.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study introduces a tailored COVID-19 model for patients with cancer, incorporating viral variants and immune-response dynamics. The model aims to optimize vaccination strategies, contributing to personalized healthcare for vulnerable groups.
Medical subject headings
- COVID-19
- Neoplasms